SK18242001A3 - Terapeutické prípravky na báze sibutramínu vrátane jeho enantiomérov a farmaceuticky prijateľných solí a orlistatu a ich použitie - Google Patents
Terapeutické prípravky na báze sibutramínu vrátane jeho enantiomérov a farmaceuticky prijateľných solí a orlistatu a ich použitie Download PDFInfo
- Publication number
- SK18242001A3 SK18242001A3 SK1824-2001A SK18242001A SK18242001A3 SK 18242001 A3 SK18242001 A3 SK 18242001A3 SK 18242001 A SK18242001 A SK 18242001A SK 18242001 A3 SK18242001 A3 SK 18242001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- compound
- orlistat
- enantiomers
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9914744.9A GB9914744D0 (en) | 1999-06-24 | 1999-06-24 | Therapeutic agents |
PCT/EP2000/005542 WO2001000205A1 (en) | 1999-06-24 | 2000-06-16 | Pharmaceutical composition containing sibutramine and orlistat |
Publications (1)
Publication Number | Publication Date |
---|---|
SK18242001A3 true SK18242001A3 (sk) | 2003-02-04 |
Family
ID=10855955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1824-2001A SK18242001A3 (sk) | 1999-06-24 | 2000-06-16 | Terapeutické prípravky na báze sibutramínu vrátane jeho enantiomérov a farmaceuticky prijateľných solí a orlistatu a ich použitie |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1187606A1 (bg) |
JP (1) | JP2003503349A (bg) |
KR (1) | KR20020015357A (bg) |
CN (1) | CN1358092A (bg) |
AU (1) | AU5533200A (bg) |
BG (1) | BG106180A (bg) |
BR (1) | BR0011880A (bg) |
CA (1) | CA2375972A1 (bg) |
CZ (1) | CZ20014613A3 (bg) |
GB (1) | GB9914744D0 (bg) |
HK (1) | HK1049278A1 (bg) |
HU (1) | HUP0201878A3 (bg) |
IL (1) | IL147079A0 (bg) |
MX (1) | MXPA01012936A (bg) |
NO (1) | NO20016224L (bg) |
PL (1) | PL352402A1 (bg) |
RU (1) | RU2229289C2 (bg) |
SK (1) | SK18242001A3 (bg) |
TR (1) | TR200103699T2 (bg) |
WO (1) | WO2001000205A1 (bg) |
ZA (1) | ZA200109989B (bg) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696495B2 (en) * | 1998-12-02 | 2004-02-24 | Snowden Pharmaceuticals, Llc | Treatment of disorders secondary to organic impairments |
US20040214804A1 (en) * | 2003-04-25 | 2004-10-28 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and an anti-obesity agent |
BRPI0517434A (pt) | 2004-10-25 | 2008-10-07 | Solvay Pharm Gmbh | composições farmacêuticas compreendendo antagonistas do receptor canabinóide cb1 e abridores de canal de potássio para o tratamento de diabetes mellitus do tipo i, obesidade e estados relacionados |
US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
CA2663254C (en) | 2006-09-15 | 2016-04-19 | Reviva Pharmaceuticals, Inc. | Synthesis, methods of using, and compositions of cycloalkylmethylamines |
KR20080046601A (ko) * | 2006-11-22 | 2008-05-27 | 에스케이케미칼주식회사 | 보관안정성이 우수한 시부트라민 함유 포접복합체 |
CN101890017A (zh) * | 2009-05-22 | 2010-11-24 | 北京奥萨医药研究中心有限公司 | 含有西布曲明和他汀类降脂药物的药物组合物及其用途 |
MX336980B (es) * | 2010-12-21 | 2016-02-09 | Senosiain S A De C V Lab | Combinacion y composicion para el tratamiento de obesidad. |
RU2642074C2 (ru) | 2011-12-30 | 2018-01-24 | Ревива Фармасьютикалс, Инк. | Композиции, синтез и способы применения производных фенилциклоалкилметиламина |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9727131D0 (en) * | 1997-12-24 | 1998-02-25 | Knoll Ag | Therapeutic agents |
-
1999
- 1999-06-24 GB GBGB9914744.9A patent/GB9914744D0/en not_active Ceased
-
2000
- 2000-06-16 CA CA002375972A patent/CA2375972A1/en not_active Abandoned
- 2000-06-16 CZ CZ20014613A patent/CZ20014613A3/cs unknown
- 2000-06-16 KR KR1020017016575A patent/KR20020015357A/ko not_active Application Discontinuation
- 2000-06-16 EP EP00940379A patent/EP1187606A1/en not_active Withdrawn
- 2000-06-16 MX MXPA01012936A patent/MXPA01012936A/es unknown
- 2000-06-16 BR BR0011880-0A patent/BR0011880A/pt not_active IP Right Cessation
- 2000-06-16 AU AU55332/00A patent/AU5533200A/en not_active Abandoned
- 2000-06-16 HU HU0201878A patent/HUP0201878A3/hu unknown
- 2000-06-16 JP JP2001505914A patent/JP2003503349A/ja active Pending
- 2000-06-16 SK SK1824-2001A patent/SK18242001A3/sk unknown
- 2000-06-16 CN CN00809372A patent/CN1358092A/zh active Pending
- 2000-06-16 IL IL14707900A patent/IL147079A0/xx unknown
- 2000-06-16 PL PL00352402A patent/PL352402A1/xx not_active Application Discontinuation
- 2000-06-16 WO PCT/EP2000/005542 patent/WO2001000205A1/en not_active Application Discontinuation
- 2000-06-16 TR TR2001/03699T patent/TR200103699T2/xx unknown
- 2000-06-16 RU RU2002102076/14A patent/RU2229289C2/ru not_active IP Right Cessation
-
2001
- 2001-12-04 BG BG106180A patent/BG106180A/bg unknown
- 2001-12-05 ZA ZA200109989A patent/ZA200109989B/xx unknown
- 2001-12-19 NO NO20016224A patent/NO20016224L/no not_active Application Discontinuation
-
2003
- 2003-01-09 HK HK03100246.9A patent/HK1049278A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
GB9914744D0 (en) | 1999-08-25 |
BG106180A (bg) | 2002-08-30 |
TR200103699T2 (tr) | 2002-04-22 |
HK1049278A1 (zh) | 2003-05-09 |
CA2375972A1 (en) | 2001-01-04 |
MXPA01012936A (es) | 2004-04-21 |
EP1187606A1 (en) | 2002-03-20 |
HUP0201878A2 (hu) | 2003-08-28 |
IL147079A0 (en) | 2002-08-14 |
WO2001000205A1 (en) | 2001-01-04 |
HUP0201878A3 (en) | 2005-04-28 |
AU5533200A (en) | 2001-01-31 |
NO20016224D0 (no) | 2001-12-19 |
CZ20014613A3 (cs) | 2003-04-16 |
CN1358092A (zh) | 2002-07-10 |
RU2229289C2 (ru) | 2004-05-27 |
KR20020015357A (ko) | 2002-02-27 |
PL352402A1 (en) | 2003-08-25 |
BR0011880A (pt) | 2002-03-19 |
ZA200109989B (en) | 2003-02-26 |
JP2003503349A (ja) | 2003-01-28 |
NO20016224L (no) | 2002-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1039900B1 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
US6376554B1 (en) | Method of treating sexual dysfunction | |
US6376552B1 (en) | Treatment of gallstones | |
SK18242001A3 (sk) | Terapeutické prípravky na báze sibutramínu vrátane jeho enantiomérov a farmaceuticky prijateľných solí a orlistatu a ich použitie | |
US6355685B1 (en) | Method of treating anxiety disorders | |
US6441046B1 (en) | Control of metabolism | |
SK18822001A3 (sk) | Terapeutické činidlá | |
US6232347B1 (en) | Treatment of osteoarthritis | |
AU773490B2 (en) | Treatment of osteoarthritis | |
US6803387B1 (en) | Treatment of neuropathic pain or fibromyalgia | |
US6403650B1 (en) | Treatment of pulmonary hypertension | |
US6288125B1 (en) | Treatment of hiatial hernia | |
US6433020B1 (en) | Treatment of cardiovascular disease | |
CA2367045A1 (en) | Treatment of certain cancers associated with weight gain | |
CA2368416A1 (en) | Treatment of gallstones |